Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome

Transplantation

Volumn 87, Issue 9, 2009, Pages 1377-1380

  Yapici, Ünsal ^a   Bemelman, Frëderike J ^a   Scheepstra, Cornelis G ^a   Roelofs, Joris J T H ^a   Claessen, Nike ^a   Van Der Loos, Chris ^a   Van Donselaar Van Der Pant, Karlijn ^a   Bouts, Antonia H M ^a   Idu, Mirza M ^a   Rowshani, Ajda T ^a   Ten Berge, Ineke J M ^a   Florquin, Sandrine ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute rejection; Fibrosis; Inflammation; Regulatory T cells; Renal transplantation; TGF

Indexed keywords

CD3 ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY TUBULE FUNCTION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD3; CHILD; FEMALE; FIBROSIS; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RNA, MESSENGER; TISSUE DONORS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649600983     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a24a4b     Document Type: Article

References (25)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
2. Ashraf S, Parrott NR, Dyer P, et al. Clinical response and temporal patterns of acute cellular rejection: Relationship to chronic transplant nephropathy. Transpl Int 1998; 11(suppl 1): S5.
3. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3: 253.
4. Meloni F, Vitulo P, Bianco AM, et al. Regulatory CD4-CD25-T cells in the peripheral blood of lung transplant recipients: Correlation with transplant outcome. Transplantation 2004; 77: 762.
5. Demirkiran A, Kok A, Kwekkeboom J, et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl2006; 12: 277.
6. Salama AD, Najafian N, Clarkson MR, et al. Regulatory CD25-T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1643.
7. Racusen LC. T-regulatory cells in human transplantation. Am J Transplant 2008; 8: 1359.
8. Muthukumar T, Dadhania D, Ding R, et al. MessengerRNAfor FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342.
9. Bunnag S, Allanach K, Jhangri GS, et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008; 8: 1423.
10. Veronese F, Rotman S, Smith RN, et al. Pathological and clinical correlates of FOXP3- cells in renal allografts during acute rejection. Am J Transplant 2007; 7: 914.
11. Bestard O, Cruzado JM, Rama I, et al. Presence of FoxP3-regulatory T cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008; 19: 2020.
12. Grimbert P, Mansour H, Desvaux D, et al. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation 2007; 83: 341.
13. Scheepstra C, Bemelman FJ, van der Loos C, et al. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation 2008; 86: 772.
14. Solez K, Colvin RB, Racusen LC, et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518.
15. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant2008; 8: 753.
16. Strom TB. Rejection-More than the eye can see. N Engl J Med 2005; 353: 2394.
17. Walsh PT, Taylor DK, Turka LA. Tregs and transplantation tolerance. J Clin Invest 2004; 114: 1398.
18. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057.
19. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4-CD25-regulatory T cells. Nat Immunol2003; 4: 330.
20. Allan SE, Crome SQ, Crellin NK, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19: 345.
21. Haanstra KG, Wubben JA, Korevaar SS, et al. Expression patterns of regulatory T-cell markers in accepted and rejected nonhuman primate kidney allografts. Am J Transplant 2007; 7: 2236.
22. Dijke IE, Velthuis JH, Caliskan K, et al. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients. Transplantation 2007; 83: 1477.
23. Mansour H,HomsS, Desvaux D, et al. Intragraft levels of Foxp3mRNA predict progression in renal transplants with borderline change. J Am Soc Nephrol 2008; 19: 2277.
24. Andersson J, Tran DQ, Pesu M, et al. CD4-FoxP3-regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med 2008; 205: 1975.
25. Shevach EM, Tran DQ, Davidson TS, et al. The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function. Eur J Immunol 2008; 38: 915.